2nd Quarter - Report

MILLER STRATEGIES, LLC for ULTRAGENYX PHARMACEUTICAL INC.

Firm
Client
Income
$140,000
Expenses
—

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Medical/Disease Research/Clinical Labs MED

Issues relating to rare disease and patient access.

LobbyistCovered position, as disclosed
ASHLEY GUNN —
NATALIE MCINTYRE —
JEFFREY MILLER —

Contacted: Centers For Medicare and Medicaid Services (CMS); Executive Office of the President (EOP); Food & Drug Administration (FDA)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.